OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Live / Registered — Registered (as of 28 Oct 2025)
What this means for you
Registered since 28 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90733729
- Registration number
- 8005173
- Mark type
- Slogan / phrase
- Filed
- 25 May 2021
- Published for opposition
- 16 Aug 2022
- Registered
- 28 Oct 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing health information
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 28 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 08 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Oct 2025 — USE AMENDMENT FILED
- 06 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 23 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2025 — SOU EXTENSION 5 GRANTED
- 07 Apr 2025 — SOU EXTENSION 5 FILED
- 23 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2024 — SOU EXTENSION 4 GRANTED
- 07 Oct 2024 — SOU EXTENSION 4 FILED